Original Article

Rheumatology International

, Volume 32, Issue 3, pp 601-606

First online:

Correlation between serum concentrations of soluble Fas (CD95/Apo-1) and IL-18 in patients with systemic lupus erythematosus

  • Maryam SahebariAffiliated withRheumatic Diseases Research Center, Ghaem Hospital, Faculty of Medicine, Mashhad University of Medical Sciences
  • , Zahra RezaieyazdiAffiliated withRheumatic Diseases Research Center, Ghaem Hospital, Faculty of Medicine, Mashhad University of Medical Sciences Email author 
  • , Mohammadreza J. NakhjavaniAffiliated withTabriz University of Medical Sciences
  • , Mohammadreza HatefAffiliated withRheumatic Diseases Research Center, Ghaem Hospital, Faculty of Medicine, Mashhad University of Medical Sciences
  • , Mahmoud MahmoudiAffiliated withImmunology Research Center, Faculty of Medicine, Mashhad University of Medical Sciences
  • , Saaid AkhlaghiAffiliated withRheumatic Diseases Research Center, Ghaem Hospital, Faculty of Medicine, Mashhad University of Medical Sciences

Rent the article at a discount

Rent now

* Final gross prices may vary according to local VAT.

Get Access

Abstract

Recent researches suggest that imbalance in apoptotic process may lead to susceptibility to systemic lupus erythematosus (SLE). Production of pro-inflammatory cytokines, such as IL-18, has important role in autoimmune process in lupus. There are cumulative data on the pro-apoptotic role of IL-18, in the Fas-mediated apoptosis. Soluble Fas (Apo/1-CD95) is a marker of apoptosis that appears to increase in serum of SLE patients. Previous studies demonstrated increasing serum concentrations of soluble Fas (sFas) and IL-18 in SLE. To assess the correlation between serum concentrations of sFas and IL-18 in SLE patients, 114 SLE patients were selected randomly at the different stages of disease activity according to SLEDAI2K. IL-18 and sFas serum concentrations were compared in patients and fifty randomly selected healthy volunteers. The correlations of IL-18 and sFas serum concentrations with SLEDAI2K and with each other were evaluated in patients. There were a significant difference between serum concentrations of sFas and IL-18 in the case and control groups (P = 0.001). There was a significant correlation between serum concentrations of sFAS and IL-18 in SLE patients (P < 0.0001, r = 0.411). The elevations of IL-18 and sFas(Apo/1-CD95) serum concentrations in SLE patients are significantly correlated.

Keywords

Soluble Fas (CD95/Apo-1) Interleukine-18(IL-18) Systemic lupus erythematosus Apoptosis